Artal Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-500,000
| Closed | -$13.8M | – | 111 |
|
|
2023
Q2 | $13.8M | Buy |
+500,000
| New | +$13.8M | 0.43% | 34 |
|
|
2022
Q2 | – | Sell |
-800,100
| Closed | -$18.9M | – | 139 |
|
|
2022
Q1 | $18.9M | Sell |
800,100
-449,900
| -36% | -$10.7M | 0.79% | 31 |
|
|
2021
Q4 | $42.8M | Sell |
1,250,000
-250,000
| -17% | -$8.55M | 1.16% | 21 |
|
|
2021
Q3 | $26.6M | Buy |
+1,500,000
| New | +$26.6M | 0.59% | 37 |
|
|
2021
Q2 | – | Sell |
-75,000
| Closed | -$1.94M | – | 156 |
|
|
2021
Q1 | $1.94M | Sell |
75,000
-58,000
| -44% | -$1.5M | 0.03% | 126 |
|
|
2020
Q4 | $2.68M | Hold |
133,000
| – | – | 0.06% | 111 |
|
|
2020
Q3 | $2.6M | Sell |
133,000
-7,000
| -5% | -$137K | 0.06% | 104 |
|
|
2020
Q2 | $2.47M | Buy |
+140,000
| New | +$2.47M | 0.07% | 104 |
|